SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has ...
Several types of insulin pumps are being recalled by a medical device company because of a dangerous flaw that could affect more than 322,000 users with Type 1 diabetes. The Food and Drug ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback